Form Approved: OMB No[removed]; Expiration Date: [removed]SUPPLEMENTARY INFORMATION CERTIFICATE OF A PHARMACEUTICAL PRODUCT Department of Health and Human Services

First Page		Document Content
Pharmaceutical industry Food and Drug Administration Medicine Drug safety Certificate of pharmaceutical product New Drug Application Public key certificate Over-the-counter drug Pharmaceutical sciences Pharmaceuticals policy Pharmacology		Form Approved: OMB No[removed]; Expiration Date: [removed]SUPPLEMENTARY INFORMATION CERTIFICATE OF A PHARMACEUTICAL PRODUCT Department of Health and Human Services Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 591,69 KB Share Document on Facebook

	Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace DocID: 1uvYN - View Document
	Emergency Use: means the use of a test article on a human subject in a life-threatening situation in DocID: 1riMu - View Document
	United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. Senate DocID: 1riEa - View Document
	Microsoft Word - FINAL 10K2014-Cover Page final to print DocID: 1r76P - View Document
	Clark Transfer, Inc. Owner-Operator Application IMPORTANT NOTICE REGARDING BACKGROUND REPORTS DocID: 1qZGZ - View Document